News

Today, International Women’s Day, the European Drugs Winter School ( EDWS) draws to a close, having explored the theme of ‘Gender-sensitive approaches to drug-related issues'. During the course, the following sessions were...

Extreme drug-related violence is putting a strain on local communities and society, and corruption is facilitating drug trafficking and undermining the rule of law. These are among the insights shared in EU...

Drug trafficking is a highly profitable commercial activity and remains a core business for organised crime groups across Europe today. Understanding the reality of the European drug market requires a holistic approach...

Today, the 59th meeting of the EMCDDA Scientific Committee drew to a close and we said farewell and a heartfelt thank you to its members. For three decades, the Scientific Committee has...

This week, EMCDDA experts will join over 150 officials from Latin American, Caribbean and EU agencies in the annual COPOLAD III meeting, taking place from 20–21 February in La Paz, Bolivia (...

Message from the Director 1/2024 I am delighted to announce today the publication of the latest EMCDDA work programme, which outlines our activities for 2024–2026. This programme represents a milestone in our...

This week, the EMCDDA is co-organising, with the Jamaican National Council on Drug Abuse, a series of technical meetings under the COPOLAD III programme. Taking place in Kingston, the events will focus...

What are the latest changes in the EU opioids market? How are global geopolitical developments impacting supply? Are heroin trafficking routes changing? To what extent do synthetic opioids pose a threat to...

A delegation from the Narcotics and Psychotropic Drug Control Agency of the Libyan Ministry of the Interior is visiting the EMCDDA today for the first time. The two-day visit is organised under...

This month, Belgium took over the rotating presidency of the Council of the EU with a promise to 'protect our people, strengthen our economy and prepare for our shared future'. Over the...

As the curtain falls on 2023, we look back on a year steeped in significance for the EMCDDA. While we commemorated 30 years since the agency's creation, we also prepared for a...

The EMCDDA and the Correlation – European Harm Reduction Network ( C-EHRN) have published today the latest overview on drug consumption rooms (DCRs) in Europe. The purpose of the report is to...

Registration opens today for the next European Conference on Addictive Behaviours and Dependencies (Lisbon Addictions 2024) taking place in Lisbon from 23–25 October 2024. The multidisciplinary event will showcase cutting-edge scientific research...

Health and social responses for migrants who use drugs are explored in a new EMCDDA miniguide launched today to mark International Migrants Day. The resource is one of a series of miniguides...

On the eve of World AIDS Day, the EMCDDA showcases the latest data on HIV among people who inject drugs (PWID) and explores how countries are performing on global health sector objectives...

EMCDDA Director Alexis Goosdeel is at the European Parliament today where he will be presenting the European Drug Report 2023: Trends and Developments (EDR 2023) to members of the Committee for Civil...

Health risk communication strategies for drug checking services in Europe is the focus of a new EMCDDA manual out today. The resource provides staff working in these services with practical guidance on...

Cannabis products are becoming increasingly potent and diverse, while collaboration between criminal groups is creating new security risks in Europe. These are among the conclusions of a new analysis — EU Drug...

This week, the EMCDDA has launched a call to scientists interested in applying to be on a list of experts who may assist the European Union Drugs Agency (EUDA) in the risk...

Today, the EMCDDA has launched a call for expression of interest in membership of the Scientific Committee of the European Union Drugs Agency (EUDA). The EUDA, which will replace the EMCDDA, will...